Literature DB >> 20387098

Prediction of the corneal permeability of drug-like compounds.

Heidi Kidron1, Kati-Sisko Vellonen, Eva M del Amo, Anita Tissari, Arto Urtti.   

Abstract

PURPOSE: To develop a computational model for optimisation of low corneal permeability, which is a key feature in ocular drug development.
METHODS: We have used multivariate analysis to build corneal permeability models based on a structurally diverse set of 58 drug-like compounds.
RESULTS: According to the models, the most important parameters for permeability are logD at physiologically relevant pH and the number of hydrogen bonds that can be formed. Combining these descriptors resulted in models with Q (2) and R (2) values ranging from 0.77 to 0.79. The predictive capability of the models was verified by estimating the corneal permeability of an external data set of 11 compounds and by using predicted permeability values to calculate the aqueous humour concentrations in the steady-state of seven compounds. The predicted values correlated well with experimental values.
CONCLUSION: The developed models are useful in early drug development to predict the corneal permeability and steady-state drug concentration in aqueous humor without experimental data.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20387098     DOI: 10.1007/s11095-010-0132-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  31 in total

1.  Biopharmaceutical evaluation of ibufenac, ibuprofen, and their hydroxyethoxy analogs in the rabbit eye.

Authors:  C S Rao; R D Schoenwald; C F Barfknecht; S L Laban
Journal:  J Pharmacokinet Biopharm       Date:  1992-08

2.  Theoretical calculation and prediction of brain-blood partitioning of organic solutes using MolSurf parametrization and PLS statistics.

Authors:  U Norinder; P Sjöberg; T Osterberg
Journal:  J Pharm Sci       Date:  1998-08       Impact factor: 3.534

3.  Structure-permeability Relationships for Transcorneal Penetration.

Authors:  A P Worth; M T Cronin
Journal:  Altern Lab Anim       Date:  2000 May-Jun       Impact factor: 1.303

4.  The relations between ionic and non-ionic diffusion of sulfonamides across the rabbit cornea.

Authors:  L M Jankowska; A Bar-Ilan; T H Maren
Journal:  Invest Ophthalmol Vis Sci       Date:  1986-01       Impact factor: 4.799

5.  Corneal penetration behavior of beta-blocking agents I: Physiochemical factors.

Authors:  R D Schoenwald; H S Huang
Journal:  J Pharm Sci       Date:  1983-11       Impact factor: 3.534

6.  Culture model of human corneal epithelium for prediction of ocular drug absorption.

Authors:  E Toropainen; V P Ranta; A Talvitie; P Suhonen; A Urtti
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-11       Impact factor: 4.799

7.  Movement of horseradish peroxidase in the cornea, sclera and the anterior uvea.

Authors:  A M Tonjum
Journal:  Acta Ophthalmol (Copenh)       Date:  1977-10

8.  Transport of acebutolol through rabbit corneal epithelium.

Authors:  Kouichi Kawazu; Akemi Oshita; Tadahiro Nakamura; Mikiro Nakashima; Nobuhiro Ichikawa; Hitoshi Sasaki
Journal:  Biol Pharm Bull       Date:  2006-04       Impact factor: 2.233

9.  Disposition of cyclophosphamide in the rabbit and human cornea.

Authors:  R D Schoenwald; J A Houseman
Journal:  Biopharm Drug Dispos       Date:  1982 Jul-Sep       Impact factor: 1.627

10.  Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.

Authors:  S Winiwarter; N M Bonham; F Ax; A Hallberg; H Lennernäs; A Karlén
Journal:  J Med Chem       Date:  1998-12-03       Impact factor: 7.446

View more
  8 in total

1.  General Pharmacokinetic Model for Topically Administered Ocular Drug Dosage Forms.

Authors:  Feng Deng; Veli-Pekka Ranta; Heidi Kidron; Arto Urtti
Journal:  Pharm Res       Date:  2016-07-18       Impact factor: 4.200

2.  Vector delivery technique affects gene transfer in the cornea in vivo.

Authors:  Rajiv R Mohan; Ajay Sharma; Tyler C Cebulko; Ashish Tandon
Journal:  Mol Vis       Date:  2010-11-27       Impact factor: 2.367

Review 3.  Polysaccharides in Ocular Drug Delivery.

Authors:  Natallia Dubashynskaya; Daria Poshina; Sergei Raik; Arto Urtti; Yury A Skorik
Journal:  Pharmaceutics       Date:  2019-12-24       Impact factor: 6.321

4.  Synthesis and multifaceted pharmacological activity of novel quinazoline NHE-1 inhibitors.

Authors:  Alexander Spasov; Alexander Ozerov; Pavel Vassiliev; Vadim Kosolapov; Denis Babkov; Natalia Gurova; Aida Kucheryavenko; Ludmila Naumenko; Viktor Sirotenko; Alena Taran; Roman Litvinov; Alexander Borisov; Vladlen Klochkov; Darya Merezhkina; Mikhail Miroshnikov; Georgy Uskov; Nadezhda Ovsyankina
Journal:  Sci Rep       Date:  2021-12-21       Impact factor: 4.379

5.  Eyes on Lipinski's Rule of Five: A New "Rule of Thumb" for Physicochemical Design Space of Ophthalmic Drugs.

Authors:  Thomas K Karami; Shumet Hailu; Shaoxin Feng; Richard Graham; Hovhannes J Gukasyan
Journal:  J Ocul Pharmacol Ther       Date:  2021-12-14       Impact factor: 2.671

6.  5-(Sulfamoyl)thien-2-yl 1,3-oxazole inhibitors of carbonic anhydrase II with hydrophilic periphery.

Authors:  Stanislav Kalinin; Alexander Kovalenko; Annika Valtari; Alessio Nocentini; Maxim Gureev; Arto Urtti; Mikhail Korsakov; Claudiu T Supuran; Mikhail Krasavin
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

7.  Topical Nanoemulsion of a Runt-related Transcription Factor 1 Inhibitor for the Treatment of Pathologic Ocular Angiogenesis.

Authors:  Santiago Delgado-Tirado; Lucia Gonzalez-Buendia; Miranda An; Dhanesh Amarnani; Daniela Isaacs-Bernal; Hannah Whitmore; Said Arevalo-Alquichire; David Leyton-Cifuentes; Jose M Ruiz-Moreno; Joseph F Arboleda-Velasquez; Leo A Kim
Journal:  Ophthalmol Sci       Date:  2022-04-20

8.  Partitioning and Spatial Distribution of Drugs in Ocular Surface Tissues.

Authors:  Anusha Balla; Seppo Auriola; Angus C Grey; Nicholas J Demarais; Annika Valtari; Emma M Heikkinen; Elisa Toropainen; Arto Urtti; Kati-Sisko Vellonen; Marika Ruponen
Journal:  Pharmaceutics       Date:  2021-05-04       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.